Fiber knob modifications overcome low, heterogeneous expression of the coxsackievirus-adenovirus receptor that limits adenovirus gene transfer and oncolysis for human rhabdomyosarcoma cells

Cancer Research

Volumn 61, Issue 7, 2001, Pages 2953-2960

  Cripe, Timothy P ^a   Dunphy, Edward J ^b   Holub, Alison D ^b   Saini, Arvind ^b   Vasi, Neeti H ^a   Mahller, Yoni Y ^a   Collins, Margaret H ^a   Snyder, Jean D ^a   Krasnykh, Victor ^c   Curiel, David T ^c   Wickham, Thomas J ^d   DeGregori, James ^e   Bergelson, Jeffrey M ^f   Currier, Mark A ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b University of Wisconsin Children's Hospital   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d GENVEC INC   (United States)

^e UNIVERSITY OF COLORADO   (United States)

^f CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE RECEPTOR; INTEGRIN; VIRUS RECEPTOR;

ADENOVIRUS; ARTICLE; CONTROLLED STUDY; COXSACKIE VIRUS; GENE EXPRESSION; GENE TRANSFER; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHABDOMYOSARCOMA; TRANSGENE; VIRUS GENE;

ADENOVIRIDAE; ANTIGENS, CD; CAPSID; GENE TRANSFER TECHNIQUES; HUMANS; INTEGRIN ALPHAV; MUTATION; RECEPTORS, VIRUS; RHABDOMYOSARCOMA; TRANSDUCTION, GENETIC;

EID: 0035300490     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Biology and therapy of pediatric rhabdomyosarcoma
2. Second malignant neoplasms in children treated for rhabdomyosarcoma
3. Transcriptional targeting
4. Human adenovirus vectors for gene transfer into mammalian cells
5. Complexes of adenovirus with polycationic polymers and cationic lipids increase the efficiency of gene transfer in vitro and in vivo
6. Lipofectamine and related cationic lipids strongly improve adenoviral infection efficiency of primitive human hematopoietic cells
7. Incorporation of adenovirus in calcium phosphate precipitates enhances gene transfer to airway epithelia in vitro and in vivo
8. Use of protamine to augment adenovirus-mediated cancer gene therapy
9. Reciprocal gene transfer enhancement by combinatorial adenovirus transduction and plasmid transfection
10. Isolation of a common receptor for coxsackie B viruses and adenovirus 2 and 5
11. The human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses
12. Identification of a conserved receptor-binding site on the fiber proteins of CAR-recognizing adenoviridae
13. Structural analysis of the mechanism of adenovirus binding to its human cellular receptor, CAR
14. Construction of a pseudoreceptor that mediates transduction by adenoviruses expressing a ligand in fiber or penton base
15. The murine CAR homolog is a receptor for coxsackie B viruses and adenoviruses
16. MUC1 and other sialoglycoconjugates inhibit adenovirus-mediated gene transfer to epithelial cells
17. Adenoviral-mediated gene transfer in lymphocytes
18. Differential susceptibility of primary and established human glioma cells to adenovirus infection: Targeting via the epidermal growth factor receptor achieves fiber receptor-independent gene transfer
19. CAR-dependent and CAR-independent pathways of adenovirus vector-mediated gene transfer and expression in human fibroblasts
20. Increased in vitro and in vivo gene transfer by adenovirus vectors containing chimeric fiber proteins
21. An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor-independent cell entry mechanism
22. An advanced generation of adenoviral vectors selectively enhances gene transfer for ovarian cancer gene therapy approaches
23. Insertion of an RGD motif into the HI loop of adenovirus fiber protein alters the distribution of transgene expression of the systemically administered vector
24. RGD inclusion in the hexon monomer provides adenovirus type 5-based vectors with a fiber knob-independent pathway for infection
25. Viruses as oncotytic agents: A new age for "therapeutic" viruses?
26. The development of conditionally repticative adenoviruses for cancer therapy
27. A controlled trial of intratumoral ONYX-015, a selectively -replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer
28. Intravenous administration of ONYX-015, a selectively replicating adenovirus, induces antitumoral efficacy
29. The addition of adenovirus type 5 region E3 enables Calydon virus 787 to eliminate distant prostate tumor xenografts
30. A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo
31. A monoclonal antibody specific for the cellular receptor for the group B coxsackieviruses
32. Regulated expression of the diphtheria toxin A chain by a tumor-specific chimeric transcription factor results in selective toxicity for alveolor rhabdomyosarcoma cells
33. Up-regulation of MET but not neural cell adhesion molecule expression by the PAX3-FKHR fusion protein in alveolar rhabdomyosarcoma
34. Adenovirus-mediated transfer of the CFTR gene to lung of nonhuman primates: Biological efficacy study
35. Gene therapy: Adenovirus vectors
36. A CRAd with enhanced infectivity shows improved oncolytic potency
37. Targeting of adenovirus penton base to new receptors through replacement of its RGD motif with other receptor-specific peptide motifs
38. Adenovirus targeted to heparan-containing receptors increases its gene delivery efficiency to multiple cell types
39. The polypeptides of adenovirus. I. Evidence for multiple protein components in the virion and a comparison of types 2, 7A, and 12
40. DNA replication of first-generation adenovirus vectors in tumor cells
41. 5 promoter adenovirus internalization but not virus attachment
42. Comparative analysis of adenovirus fiber-cell interaction: Adenovirus type 2 (Ad2) and Ad9 utilize the same cellular fiber receptor but use different binding strategies for attachment
43. Maturation and lineage-specific expression of the coxsackie and adenovirus receptor in hematopoietic cells
44. Polysialylated neural cell adhesion molecule in childhood rhabdomyosarcoma
45. A decay-accelerating factor-binding strain of coxsackievirus B3 requires the coxsackievirus-adenovirus receptor protein to mediate lytic infection of rhabdomyosarcoma cells
46. Variability of adenovirus receptor density influences gene transfer efficiency and therapeutic response in head and neck cancer
47. Loss of adenoviral receptor expression in human bladder cancer cells: A potential impact on the efficacy of gene therapy
48. The dual impact of coxsackie and adenovirus receptor expression on human prostate cancer gene therapy
49. Highly augmented cytopathic effect of a fiber-mutant E1B-defective adenovirus for gene therapy of gliomas
50. An adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacy